TriPath Imaging has entered into an agreement with the Methodist Hospital of Houston to provide its SurePath liquid-based Pap test for cervical cancer screening.

As a nonprofit health care organization, the Methodist Hospital of Houston is the primary, private, adult teaching site for the Baylor College of Medicine.

“The Methodist Hospital is a leading provider of quality health care and medical education,” said Paul Sohmer, TriPath’s chairman, president and CEO. “We are pleased that they plan to add TriPath Imaging’s solution to their cervical cancer screening program,”

TriPath Imaging: